Denmark's Smoking Rate and E-cigarette Use Rise with Flavor Ban

Feb.15.2023
Denmark's Smoking Rate and E-cigarette Use Rise with Flavor Ban
Danish smoking and e-cigarette use increased from 2020 to 2022, despite a flavor ban in 2022, according to a report.

According to the latest data released by the Danish National Health Committee in February 2023, smoking and e-cigarette use have both increased in Denmark from 2020 to 2022. It is reported that a flavor ban in Denmark officially took effect on April 1, 2022.


A report has revealed the smoking rate in Denmark from 2020 to 2022.


The percentage of smokers has increased from 18% to 19%.


The percentage of smokers aged 15-29 years has increased from 23% to 25%.


The usage rate of electronic cigarettes has increased from 3% to 5%.


The usage rate of electronic cigarettes among individuals aged 15-29 is between 4% and 7%.


In the years 2020-2022, there was a significant increase in the number of fruit and candy/soft drink flavored electronic cigarettes.


The percentage of users of fruit-flavored electronic cigarettes has increased from 47% to 67%.


The percentage of candy and soft drink flavor users has increased from 21% to 32%.


The percentage of fruit-flavored e-cigarette users aged 15-29 increased from 67% to 83%.


The percentage of candy/soft drink flavor users aged 15-29 has increased from 32% to 41%.


However, the increase in Denmark's smoking rate failed to lead to an increase in the rate of quitting smoking. From 2020 to 2022, the number of e-cigarette users who completely quit smoking decreased from 41% to 38%. This indicates that the ban on electronic cigarettes may decrease their effectiveness as a smoking cessation tool.


Officials from a Danish health research institution have stated that even though Denmark has implemented a flavor ban, illegal e-cigarettes are still circulating through black markets and being sold to children and young people through social media. The Danish authorities do not have enough resources to handle the growing illegal market.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24
BAT Japan to launch two new VELO nicotine pouch flavours in February
BAT Japan to launch two new VELO nicotine pouch flavours in February
BAT Japan will roll out two new VELO nicotine pouch variants from Feb. 2, 2026: Smooth Peppermint Medium and Breezy Mango Intense. The products will be sold via the official glo & VELO online store, the glo Store Ginza and nationwide tobacco retail channels in Japan.
Jan.23 by 2FIRSTS.ai
PMTA Manufacturing Panel Sees Small Firms Warn “Unknown Is Death” as FDA Defends Review Boundaries
PMTA Manufacturing Panel Sees Small Firms Warn “Unknown Is Death” as FDA Defends Review Boundaries
During FDA’s Feb 10 PMTA roundtable (manufacturing controls panel), small ENDS manufacturers warned that uncertainty in manufacturing expectations creates existential financial risk. FDA officials reiterated review flexibility is constrained by statutory and scientific boundaries. The panel debated testing standards, documentation requirements, open-system responsibility, supply chain changes, and software updates—highlighting unresolved PMTA challenges for small manufacturers.
Feb.11
2Firsts Interview | Bengt Wiberg: Why the Oral Health Risks of Nicotine Pouches Merit Further Study
2Firsts Interview | Bengt Wiberg: Why the Oral Health Risks of Nicotine Pouches Merit Further Study
As nicotine pouches gain global traction as a lower-risk alternative to smoking, questions are emerging about their potential oral health effects. In a 2Firsts interview, Stingfree AB founder Bengt Wiberg discusses why gum irritation and oral lesions warrant closer scrutiny within the broader framework of tobacco harm reduction.
Jan.06
Consultation opens for Tasmania’s Public Health Amendment Bill 2026
Consultation opens for Tasmania’s Public Health Amendment Bill 2026
Consultation opened on February 6, 2026 for the Public Health Amendment (Prohibited Tobacco and Other Products) Bill 2026. The Bill intends to address illicit trade in tobacco, nicotine pouches and e-cigarettes, which has increased significantly across Tasmania in recent years. It proposes changes to the Public Health Act 1997 to further protect the health of Tasmanians by reducing the sale and supply of illicit tobacco, vaping and other products, and to strengthen existing tobacco control laws.
Feb.06 by 2FIRSTS.ai
Singapore New bill would raise maximum fines to S$200,000 for sellers and S$300,000 for smugglers
Singapore New bill would raise maximum fines to S$200,000 for sellers and S$300,000 for smugglers
A bill introduced in Singapore’s Parliament on Feb. 12 proposes major increases in penalties for vaping-related offences, including higher maximum fines for users, sellers and smugglers. The draft would also rename the current Tobacco (Control of Advertisements and Sale) Act as the Tobacco and Vaporisers Control Act.
Feb.28 by 2FIRSTS.ai